Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
Neurology·MeSH: Rett Syndrome
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| ion440 | IONIS PHARMACEUTICALS INC (IONS) |
Frequently asked questions
How many drugs are in development for Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome?
BioSniper tracks 1 drug in development for Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome across 1 company.
How many clinical trials target Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome?
There are 2 clinical trials targeting Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome tracked by BioSniper.
Deep-dive into Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis